PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
暂无分享,去创建一个
K. Lamperska | A. Mackiewicz | Tomasz Kolenda | Kacper Guglas | Joanna Sobocińska | Magda Kopczyńska | A. Teresiak | Renata Bliźniak | J. Mackiewicz
[1] Lanlan Wei,et al. Association of lnc‐IL17RA‐11 with increased radiation sensitivity and improved prognosis of HPV‐positive HNSCC , 2019, Journal of cellular biochemistry.
[2] Daria A. Gaykalova,et al. Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers , 2019, Nature Communications.
[3] Daolin Xie,et al. LncRNA PRINS is involved in the development of nephropathy in patients with diabetes via interaction with Smad7. , 2019, Experimental and therapeutic medicine.
[4] K. Lamperska,et al. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas , 2019, Cells.
[5] N. Issaeva,et al. HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis , 2018, Cancers of the Head & Neck.
[6] K. Lamperska,et al. lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines , 2018, Non-coding RNA.
[7] Zhihua Cui,et al. PRINS Long Noncoding RNA Involved in IP-10-Mediated Allograft Rejection in Rat Kidney Transplant. , 2018, Transplantation proceedings.
[8] Xiaohang Chen,et al. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis , 2018, Molecular immunology.
[9] Scott M Langevin,et al. Differential expression and prognostic value of long non‐coding RNA in HPV‐negative head and neck squamous cell carcinoma , 2018, Head & neck.
[10] P. Boscolo-Rizzo,et al. Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factors , 2017, Clinical Epigenetics.
[11] K. Lamperska,et al. Biological role of long non-coding RNA in head and neck cancers. , 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.
[12] Chad J. Creighton,et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.
[13] B. Erman,et al. Long noncoding RNA (lincRNA), a new paradigm in gene expression control , 2016, Functional & Integrative Genomics.
[14] Yaling Tang,et al. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma , 2017, Oncotarget.
[15] J Silvio Gutkind,et al. Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection. , 2016, Oral oncology.
[16] Maureen A. Sartor,et al. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures , 2016, Clinical Cancer Research.
[17] Howard Y. Chang,et al. Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.
[18] M. B. Gillespie,et al. Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients , 2016, Head & neck.
[19] Farooq Rashid,et al. Long Non-coding RNAs in the Cytoplasm , 2016, Genom. Proteom. Bioinform..
[20] J. R. Plaça,et al. Long Noncoding RNAs in HPV-Induced Oncogenesis , 2016 .
[21] Chi-Yuan Li,et al. RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS , 2016, Scientific Reports.
[22] M. Scholz,et al. The role of HPV RNA transcription, immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer , 2015, International journal of cancer.
[23] M. von Knebel Doeberitz,et al. p16INK4a/Ki‐67 co‐expression specifically identifies transformed cells in the head and neck region , 2015, International journal of cancer.
[24] J. Kónya,et al. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins , 2015, Archives of Virology.
[25] C. Feschotte,et al. Volatile evolution of long noncoding RNA repertoires: mechanisms and biological implications. , 2014, Trends in genetics : TIG.
[26] M. Hasegawa,et al. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma , 2014, International journal of oncology.
[27] O. Peralta-Zaragoza,et al. Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review) , 2014, Oncology reports.
[28] Binyuan Jiang,et al. The role of MALAT1 correlates with HPV in cervical cancer , 2014, Oncology letters.
[29] S. Willems,et al. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma , 2014, Epigenetics.
[30] P. Gariglio,et al. Deregulation of the miRNAs Expression in Cervical Cancer: Human Papillomavirus Implications , 2013, BioMed research international.
[31] M. Teixeira,et al. Targeting CCL5 in inflammation , 2013, Expert opinion on therapeutic targets.
[32] N. Grabe,et al. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway , 2013, International journal of cancer.
[33] Anushya Muruganujan,et al. Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.
[34] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[35] Zhi-Ming Zheng,et al. Regulation of cellular miRNA expression by human papillomaviruses. , 2011, Biochimica et biophysica acta.
[36] Howard Y. Chang,et al. Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.
[37] L. Kemény,et al. The anti‐apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non‐coding RNA, PRINS , 2010, Experimental dermatology.
[38] M. Tommasino,et al. The biological properties of E6 and E7 oncoproteins from human papillomaviruses , 2010, Virus Genes.
[39] A. Cmelak,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.
[40] E. Sturgis,et al. Trends in head and neck cancer incidence in relation to smoking prevalence , 2007, Cancer.
[41] Carole Fakhry,et al. Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.
[42] Farin Kamangar,et al. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] L. Kemény,et al. Identification and Characterization of a Novel, Psoriasis Susceptibility-related Noncoding RNA gene, PRINS* , 2005, Journal of Biological Chemistry.
[44] K. Lamperska,et al. EGOT lncRNA in head and neck squamous cell carcinomas. , 2018, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[45] Ruud H. Brakenhoff,et al. The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.